FIELD: medicine.
SUBSTANCE: invention relates to medicine, in particular to experimental pharmacology, and is intended for immunocorrection. Method of immunocorrection using extracts of fatty oils from seeds of Nigella damascena and Echinacea purpurea, including reproducing immune deficiency in laboratory rats by administering cyclophosphamide once in a dose of 200 mg/kg per the rat body weight on the first day of the experiment with the subsequent correction on the second day of the experiment, is characterized in that the correction of immune deficiency is carried out with a mixture of extracts of fatty oils from seeds of seeds of Nigella damascena and Echinacea purpurea at a volume ratio of 1:1, which is intragastrically administered to the laboratory rat, through a probe, in a dose of 4.6 ml/kg/day daily for 14 days.
EFFECT: described method of immunocorrection with a combination of components of the mixture provides a synergetic effect and effective correction of experimental immune deficiency.
1 cl, 1 tbl, 1 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD OF IMMUNOCORRECTION IN ANIMALS | 2023 |
|
RU2823498C1 |
METHOD FOR IMMUNE CORRECTION WITH API-PHYTOCOMPOSITION | 2013 |
|
RU2524658C1 |
MEDICATION, WHICH POSSESES IMMUNOSTIMULATING ACTIVITY | 2009 |
|
RU2403054C1 |
MEDICATION POSSESSING IMMUNOTROPIC ACTIVITY | 2009 |
|
RU2406524C1 |
AGENT POSSESSING IMMUNOCORRECTIVE ACTION IN CYTOSTATIC IMMUNOSUPPRESSION | 2011 |
|
RU2482861C1 |
BIOLOGICALLY ACTIVE STIMULANT AND METHOD FOR CORRECTING SECONDARY IMMUNODEFICIENCIES DUE TO ITS APPLICATION | 2006 |
|
RU2318530C2 |
AGENT SHOWING AN ADAPTOGENIC ACTIVITY AND A COMPOSITION BASED ON SAID | 1998 |
|
RU2129010C1 |
MEDICATION POSSESSING IMMUNOSTIMULATION ACTION | 2008 |
|
RU2406519C2 |
METHOD OF OSTEOPOROSIS CORRECTION AND PREVENTION OF OSTEOPOROTIC FRACTURE BY MEANS OF ENALAPRILS | 2008 |
|
RU2369390C1 |
METHOD OF OSTEOPOROSIS CORRECTION AND PREVENTION OF OSTEOPOROTIC FRACTURES BY MEANS OF LOSARTAN | 2008 |
|
RU2369391C1 |
Authors
Dates
2019-02-08—Published
2018-08-20—Filed